Preliminary evidence for bioactivity of IL-1 trap (rilonacept), a long acting IL-1 inhibitor, in systemic juvenile idiopathic arthritis

被引：0
作者：
Lovell, D.
Giannini, E.
Kimura, Y.
Lil, S.
Hashkes, R.
Reiff, A.
Wallace, C.
Onei, K.
Nadler, D.
Rosenberg, J.
Osgood, G.
Papadopoulos, J.
Radin, A.
机构：
[1] Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA
[2] Hackensack Univ, Med Ctr, Hackensack, NJ USA
[3] Cleveland Clin Fdn, Cleveland, Qld, Australia
[4] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA
[5] Childrens Hosp, Reg Med Ctr, Seattle, WA USA
[6] Univ Chicago, La Rabida Childrens Hosp, Chicago, IL 60637 USA
[7] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：693 / 693
页数：1
相关论文
共 50 条
  • [31] Genetic control of IL-1β bioactivity through differential regulation of the IL-1 receptor antagonist
    Vamvakopoulos, J
    Green, C
    Metcalfe, S
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2002, 32 (10) : 2988 - 2996
  • [32] THE EFFECT OF ANTIRHEUMATIC DRUGS ON INTERLEUKIN-1 (IL-1) ACTIVITY AND IL-1 AND IL-1 INHIBITOR PRODUCTION BY HUMAN MONOCYTES
    CHANG, DM
    BAPTISTE, P
    SCHUR, PH
    [J]. JOURNAL OF RHEUMATOLOGY, 1990, 17 (09) : 1148 - 1157
  • [33] THE USE OF A COMBINATION OF IL-1 AND IL-6 INHIBITION IN THE MANAGEMENT OF SEVERE, AGGRESSIVE, EROSIVE, SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS
    Lee, Martin
    Nicholl, Karl
    Campbell, Ian
    [J]. RHEUMATOLOGY, 2016, 55 : 157 - 157
  • [34] Infectious adverse effects during treatment with IL-1 inhibitors in patients with systemic juvenile idiopathic arthritis and autoinflammatory diseases
    Laura Fernandez-Silveira
    M Isabel González-Fernández
    Berta López-Montesinos
    Silvia Benito-Costey
    Inmaculada Calvo-Penadés
    [J]. Pediatric Rheumatology, 12 (Suppl 1)
  • [35] Rescue Treatment by Increased Doses of IL-1 Inhibitors for Macrophage Activation Syndrome in Children With Systemic Juvenile Idiopathic Arthritis
    Kostik, Mikhail
    Snegireva, Ludmila
    Dubko, Margarita
    Masalova, Vera
    Likhacheva, Tatyana
    Kornishina, Tatyana
    Chikova, Irina
    Buchinskaya, Natalia
    Kalashnikova, Olga
    Chasnyk, Vyacheslav
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S133 - S133
  • [36] REGULATION OF CARTILAGE REMODELING BY IL-1 - EVIDENCE FOR AUTOCRINE SYNTHESIS OF IL-1 BY CHONDROCYTES
    TOWLE, CA
    TRICE, ME
    OLLIVIERRE, F
    AWBREY, BJ
    TREADWELL, BV
    [J]. JOURNAL OF RHEUMATOLOGY, 1987, 14 : 11 - 13
  • [37] Blocking IL-1 in systemic inflammation
    Dinarello, CA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (09) : 1355 - 1359
  • [38] NATIVE IL-1 INHIBITOR - REPLY
    LARRICK, JW
    [J]. IMMUNOLOGY TODAY, 1989, 10 (07): : 222 - 222
  • [39] STIMULATION OF PRODUCTION OF INTERLEUKIN-1 (IL-1) AND AN IL-1 INHIBITOR IN HUMAN-MONOCYTES
    AREND, WP
    JOSLIN, FG
    MASSONI, RJ
    [J]. LYMPHOKINE RESEARCH, 1985, 4 (01): : 66 - 66
  • [40] A phenotypic shift after initiation of IL-1 receptor blockade in a boy with systemic juvenile arthritis
    C Scott
    CH Wouters
    F de Zegher
    [J]. Pediatric Rheumatology, 6 (Suppl 1)
12345